Publication | Closed Access
Fluoroquinolones Inhibit HCV by Targeting Its Helicase
33
Citations
21
References
2011
Year
Fluoroquinolones inhibit HCV replication possibly by targeting the HCV NS3 helicase. These drugs hold promise for the treatment of HCV infection.
| Year | Citations | |
|---|---|---|
Page 1
Page 1